ArboretumHome PageNews Page Jan Garfinkle Receives NVCA’s Venture Vanguard Award In observance of its 50th anniversary, the National Venture Capital Association (NVCA) is pleased to…Arboretum_JDMarch 30, 2023
Boomerang MedicalNews Page Bioelectronic Medicine Company Boomerang Medical Earns FDA Breakthrough Device Designation Boomerang Medical, a women-led bioelectronic medicine company, has been granted Breakthrough Device Designation from the…Arboretum_JDMarch 1, 2023
Flosonics MedicalNews Page Flosonics Medical Announces Publication of Observational Study in the Journal of Intensive Care Flosonics Medical, a company dedicated to improving patient care with wireless, wearable ultrasound sensors, announced…Arboretum_JDMarch 1, 2023
EQRxNews Page EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate ProgressArboretum_JDFebruary 23, 2023
Home PageNews PageStrata Oncology Strata Oncology Announces Publication of Study Validating Clinical Utility of Pan-tumor Predictive Biomarker for Checkpoint Inhibitor Immunotherapy Benefit Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today…Arboretum_JDFebruary 7, 2023
Francis MedicalNews Page Francis Medical Appoints Andrew Cleeland to Board of Directors Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor…Arboretum_JDJanuary 26, 2023
JUMPCODE GenomicsNews Page Jumpcode Genomics joins PacBio Compatible Program Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology,…Arboretum_JDJanuary 12, 2023
Home PageNews PageNewsletter Arboretum Ventures Newsletter – Special 20th Anniversary Edition View the latest news and updates from Arboretum Ventures.Arboretum_JDJanuary 6, 2023
BrightSpecHome PageNews Page BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today…Arboretum_JDDecember 14, 2022
EQRxNews Page EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency Application is based on data from the pivotal Phase 3 AENEAS trial evaluating aumolertinib as…Arboretum_JDDecember 2, 2022